ArticleInternational journal of nanomedicine2025
Targeted Delivery of Nanovaccine to Dendritic Cells via DC-Binding Peptides Induces Potent Antiviral Immunity in vivo [Expression of Concern].
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.